Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Nikkho · SciRah

Researcher profile · Semantic Scholar

S. Nikkho

Share profile

S. Nikkho — researcher profile on SciRah

h-index: 17
Works: 46
Citations: 2,528

Most-cited papers

Inhaled iloprost for severe pulmonary hypertension.
H. Olschewski, G. Simonneau, N. Galie', T. Higenbottam +19 more
2002New England Journal of Medicine1,628 citations Open access
Semantic Scholar
Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial.
G. Simonneau, A. D'Armini, H. Ghofrani, F. Grimminger +10 more
2016The Lancet Respiratory Medicine142 citations
Semantic Scholar
Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial.
H. Ghofrani, F. Grimminger, E. Grünig, Yi-Gao Huang +9 more
2016The Lancet Respiratory Medicine103 citations Open access
Semantic Scholar
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
H. Olschewski, M. Hoeper, J. Behr, R. Ewert +8 more
2010Respiratory Medicine81 citations Open access
Semantic Scholar
Quality of life in patients with chronic thromboembolic pulmonary hypertension
S. Mathai, H. Ghofrani, E. Mayer, J. Pepke-Zaba +2 more
2016European Respiratory Journal69 citations Open access
Semantic Scholar
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension
S. Nikkho, M. Richter, Eric Shen, S. Abman +15 more
2022Pulmonary Circulation55 citations Open access
Semantic Scholar
REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
R. Benza, H. Farber, A. Frost, E. Grünig +5 more
2017The Journal of Heart and Lung Transplantation40 citations Open access
Semantic Scholar
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative ‐ Group 3 Pulmonary Hypertension
L. Piccari, B. Allwood, K. Antoniou, Jonathan H. Chung +7 more
2023Pulmonary Circulation39 citations Open access
Semantic Scholar
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
M. Halank, M. Hoeper, H. Ghofrani, F. Meyer +7 more
2017Respiratory Medicine39 citations Open access
Semantic Scholar
REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.
R. Benza, H. Farber, A. Frost, H. Ghofrani +7 more
2017The Journal of Heart and Lung Transplantation37 citations Open access
Semantic Scholar
Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
S. Nathan, V. Cottin, J. Behr, M. Hoeper +15 more
2021The Journal of Heart and Lung Transplantation34 citations Open access
Semantic Scholar
Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
V. McLaughlin, P. Jansa, J. Nielsen-Kudsk, M. Halank +16 more
2017BMC Pulmonary Medicine25 citations Open access
Semantic Scholar
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC
Eva-Maria Becker-Pelster, Michael G. Hahn, M. Delbeck, L. Dietz +15 more
2022Respiratory Research22 citations Open access
Semantic Scholar
Updating clinical endpoint definitions
P. Hassoun, S. Nikkho, E. Rosenzweig, Gail Moreschi +8 more
2013Pulmonary Circulation22 citations Open access
Semantic Scholar
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
O. Shlobin, Eric Shen, S. Wort, L. Piccari +4 more
2024Pulmonary Circulation21 citations Open access
Semantic Scholar
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
O. Sitbon, S. Nikkho, R. Benza, C. Deng +8 more
2020Pulmonary Circulation20 citations Open access
Semantic Scholar
Pulmonary thromboembolic events in COVID‐19—A systematic literature review
Paul M Overton, M. Toshner, C. Mulligan, P. Vora +4 more
2022Pulmonary Circulation18 citations Open access
Semantic Scholar
Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
S. Nathan, P. Fernandes, Mitchell Psotka, P. Vitulo +4 more
2022Pulmonary Circulation15 citations Open access
Semantic Scholar
Efficacy and Safety of Inhaled Iloprost in Japanese Patients With Pulmonary Arterial Hypertension - Insights From the IBUKI and AIR Studies.
T. Saji, Masafumi Myoishi, K. Sugimura, N. Tahara +6 more
2016Circulation Journal14 citations Open access
Semantic Scholar
Repurposing of medications for pulmonary arterial hypertension
M. Toshner, E. Spiekerkoetter, H. Bogaard, G. Hansmann +2 more
2020Pulmonary Circulation12 citations Open access
Semantic Scholar
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
R. Benza, A. Boucly, H. Farber, A. Frost +8 more
2021The Journal of Heart and Lung Transplantation10 citations Open access
Semantic Scholar
Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies
T. Thenappan, Nadine Al-Naamani, S. Ghio, H. Ghofrani +6 more
2020Pulmonary Circulation10 citations Open access
Semantic Scholar
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
G. T. Milne, P. Sandner, Kathleen A. Lincoln, P. C. Harrison +444 more
2017BMC Pharmacology and Toxicology10 citations Open access
Semantic Scholar
Application of the REVEAL risk score calculator 2.0 in the PATENT study.
R. Benza, H. Farber, A. Frost, H. Ghofrani +5 more
2021International Journal of Cardiology9 citations Open access
Semantic Scholar
Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
S. Nikkho, P. Fernandes, R. White, C. Deng +2 more
2020Pulmonary Circulation9 citations Open access
Semantic Scholar
Measuring health-related quality of life with the Euroqol EQ-5D instrument in clinical trials of new treatments for pulmonary hypertension
W. Seeger, K. Fichte, C. Miltenburger, S. Nikkho +3 more
20019 citations
Semantic Scholar
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension
P. Vitulo, L. Piccari, S. Wort, O. Shlobin +7 more
2024Pulmonary Circulation7 citations Open access
Semantic Scholar
Real‐world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative's Real‐world Evidence Working Group
K. Morland, C. Gerges, J. Elwing, S. Visovatti +27 more
2023Pulmonary Circulation6 citations Open access
Semantic Scholar
Application of the REVEAL risk score calculator 2.0 in the CHEST study.
R. Benza, H. Farber, A. Frost, H. Ghofrani +5 more
2022Respiratory Medicine6 citations Open access
Semantic Scholar
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison
Chen Wang, Zhi-Cheng Jing, Yi-Gao Huang, Da-Xin Zhou +6 more
2016Heart Asia6 citations Open access
Semantic Scholar
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
S. Nathan, L. Piccari, Steven H. Abman, A. Balasubramanian +8 more
2025Pulmonary Circulation5 citations Open access
Semantic Scholar
Enhancing Drug Development for Paediatric Pulmonary Hypertension—An Integrative Perspective
Steven H. Abman, S. Nikkho, Rolf M. F. Berger, M. D. Del Cerro +11 more
2025Pulmonary Circulation3 citations Open access
Semantic Scholar
Riociguat in Combination With Prostacyclin Analogs for the Treatment of Pulmonary Arterial Hypertension (PAH): A Subgroup Analysis of the PATENT Studies
I. Preston, N. Hill, H. Ghofrani, M. Hoeper +5 more
20152 citations
Semantic Scholar
The Innovative Drug Development Initiative (IDDI) of the Pulmonary Vascular Research Institute (PVRI)
P. Corris, S. Nikkho, P. Fernandes
2020Pulmonary Circulation1 citations Open access
Semantic Scholar
Validation of REVEAL Risk Score Calculator 2.0 in Patients with CTEPH in the Phase III CHEST Study.
R. Benza, H. Farber, A. Frost, H. Ghofrani +5 more
2020The Journal of Heart and Lung Transplantation1 citations
Semantic Scholar
FRI0445 Efficacy and Safety of Riociguat in Patients with Pulmonary Arterial Hypertension (PAH) Associated with Connective Tissue Disease (CTD): Results from Patent-1 and Patent-2
C. Denton, J. Coghlan, H. Ghofrani, F. Grimminger +8 more
20151 citations
Semantic Scholar
Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study
M. Hoeper, H. Ghofrani, M. Halank, F. Meyer +8 more
20151 citations
Semantic Scholar
Updating Clinical Endpoints in Pulmonary Arterial Hypertension: When Challenges are Welcome
P. Hassoun, S. Nikkho, R. Oudiz
2013Pulmonary Circulation1 citations Open access
Semantic Scholar
Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects.
J. Nagelschmitz, S. Saleh, S. Ligges, Melanie Seidel-Greven +4 more
2026British Journal of Clinical Pharmacology0 citations Open access
Semantic Scholar
Pathogenesis and Phenotypes of Pulmonary Vascular Disease in COPD: A Consensus Statement From the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative – PH Group 3 Workstream
L. Piccari, Katarina Zeder, A. Balasubramanian, Brian W. Allwood +9 more
2026Pulmonary Circulation0 citations Open access
Semantic Scholar
Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study.
R. Benza, Harrison W. Farber, A. Frost, H. Ghofrani +5 more
2020The Journal of Heart and Lung Transplantation0 citations
Semantic Scholar
Erratum for Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
O. Sitbon, S. Nikkho, R. Benza
2020Pulmonary Circulation0 citations Open access
Semantic Scholar
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with CTEPH in the CHEST-1 study
I. Preston, Nadine Al-Naamani, A. Torbicki, H. Ghofrani +4 more
20150 citations
Semantic Scholar
Calculation of REVEAL scores for patients with PAH receiving riociguat in the PATENT-2 study
R. Benza, A. Frost, H. Farber, H. Ghofrani +7 more
20150 citations
Semantic Scholar
Application of REVEAL Risk Score to Patients With PAH Receiving Riociguat in the PATENT-2 Study
R. Benza, A. Frost, H. Farber, H. Ghofrani +7 more
20150 citations
Semantic Scholar
Effect of riociguat on pulmonary arterial compliance (PAC) in patients with PAH in PATENT-1
I. Preston, Nadine Al-Naamani, S. Ghio, H. Ghofrani +4 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Ghofrani×17
Invite
H. Ghofrani — researcher profile on SciRah
M. Hoeper×16
Invite
M. Hoeper — researcher profile on SciRah
C. Meier×15
Invite
C. Meier — researcher profile on SciRah
R. Benza×12
Invite
R. Benza — researcher profile on SciRah

×10

Invite

H. Farber — researcher profile on SciRah

Invite

P. Hassoun — researcher profile on SciRah

Invite

A. Frost — researcher profile on SciRah

Invite

L. Piccari — researcher profile on SciRah

Invite

D. Busse — researcher profile on SciRah

Invite

P. Corris — researcher profile on SciRah

F. Grimminger×6

Invite

F. Grimminger — researcher profile on SciRah

S. Rosenkranz×6

Invite

S. Rosenkranz — researcher profile on SciRah